Learning from aprotinin--mandatory trials of comparative efficacy and safety needed
- PMID: 18287607
- DOI: 10.1056/NEJMe0800268
Learning from aprotinin--mandatory trials of comparative efficacy and safety needed
Comment on
-
Aprotinin during coronary-artery bypass grafting and risk of death.N Engl J Med. 2008 Feb 21;358(8):771-83. doi: 10.1056/NEJMoa0707571. N Engl J Med. 2008. PMID: 18287600
-
The effect of aprotinin on outcome after coronary-artery bypass grafting.N Engl J Med. 2008 Feb 21;358(8):784-93. doi: 10.1056/NEJMoa0707768. N Engl J Med. 2008. PMID: 18287601
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical